Stock A087010 PEPTRON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Peptron, Inc.

Equities

A087010

KR7087010005

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-04-25 EDT 		5-day change 1st Jan Change
28,200 KRW +3.49% Intraday chart for Peptron, Inc. +9.51% -29.94%
2023 Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal MT
2023 Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI

Business Summary

Peptron, Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The Company also provides peptide synthesis services. The Company manufactures raw material medicines and some functional cosmetics. The Company distributes its products within domestic market and to overseas markets.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Bio Sector
68.3 %
4,545 78.2 % 2,283 68.3 % -49.76%
Pharmaceutical Division
31.7 %
1,269 21.8 % 1,059 31.7 % -16.56%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
83.3 %
5,381 92.6 % 2,783 83.3 % -48.28%
Overseas
16.7 %
433 7.4 % 559 16.7 % +29.10%

Managers

Managers TitleAgeSince
Min-Ho Song CEO
 Chief Executive Officer 63 21-03-29
Ho-Il Choi CEO
 Chief Executive Officer 58 97-11-20
Seung-Gu Jang DFI
 Director of Finance/CFO 58 99-06-30
Gi-Young Lee AUD
 Comptroller/Controller/Auditor 59 17-03-26

Members of the board

Members of the board TitleAgeSince
Ho-Il Choi CEO
 Chief Executive Officer 58 97-11-20
Seung-Gu Jang DFI
 Director of Finance/CFO 58 99-06-30
Young-Go Jung BRD
 Director/Board Member 49 14-03-30
Hyo-Seop Kim BRD
 Director/Board Member 53 15-06-30
Sang-Heon Lee BRD
 Director/Board Member 57 -
Min-Ho Song CEO
 Chief Executive Officer 63 21-03-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,626,853 18,496,711 ( 89.67 %) 73,961 ( 0.3586 %) 89.67 %

Shareholders

NameEquities%Valuation
Ho-Il Choi
8.378 %
1,728,200 8.378 % 36 M ₩
Peptron, Inc. Employee Stock Option Associate
0.9480 %
195,534 0.9480 % 4 M ₩
Seung-Gu Jang
0.8339 %
172,010 0.8339 % 4 M ₩
POLARIS UNO, INC.
0.6441 %
132,853 0.6441 % 3 M ₩
Mi-yong Kang
0.1585 %
32,700 0.1585 % 689 827 ₩

Company contact information

Peptron, Inc.

37-24 Yuseong-daero 1628beon-gil Yuseong-gu

34054, Daejeon

+

http://www.peptron.co.kr
address Peptron, Inc.(A087010)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per Business

Sales per region

Sector Bio Therapeutic Drugs

1st Jan change Capi.
PEPTRON, INC. Stock Peptron, Inc.
-29.94% 423M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.44% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.93% 95.28B
ARGENX SE Stock argenx SE
+1.66% 22.15B
BIONTECH SE Stock BioNTech SE
-15.36% 21.02B
GENMAB A/S Stock Genmab A/S
-8.58% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.12% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.14% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.44% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A087010 Stock
  4. Company Peptron, Inc.